Brown Brothers Harriman & Co. Purchases New Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Brown Brothers Harriman & Co. purchased a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 1,194 shares of the company’s stock, valued at approximately $31,000. Several other institutional investors also recently added to or reduced their stakes in the stock. BlackRock Inc. […]

Related Keywords

Robertw Baird ,Jolanda Howe ,Raymond James ,Brown Brothers Harriman Co ,Mirum Pharmaceuticals Inc ,Nasdaq ,News Ratings For Mirum Pharmaceuticals Daily ,Vanguard Group Inc ,Quarter For Mirum Pharmaceuticals ,Mirum Pharmaceuticals Stock ,Mirum Pharmaceuticals Profile ,Blackrock Inc ,Mirum Pharmaceuticals ,Polar Capital Holdings Plc ,Free Report ,Street Corp ,Capital Holdings Plc ,Pictet Asset Management ,Director Michael ,Visit Holdingschannel ,Mirum Pharmaceuticals Daily ,Nasdaq Mirm ,Smirm ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,